id
int64 0
34.5k
| question
stringlengths 7
1.83k
| choice0
stringlengths 1
1k
| choice1
stringlengths 1
984
| choice2
stringlengths 1
1.82k
| choice3
stringlengths 1
1.82k
| choice4
stringlengths 1
1.94k
| label
int64 0
4
| task
stringclasses 3
values |
|---|---|---|---|---|---|---|---|---|
1,084 |
Clematichinenoside Bの異なる表現は?
|
フェネルジン
|
UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine
|
2,4-Dinitrophenol
|
シルシリオール
|
クレマチキネノシド B
| 4 |
replace
|
33,718 |
咽頭結膜熱の異なる表現は?
|
Pharyngoconjunctival fever
|
Infantile-onset multisystem neurologic, endocrine, and pancreatic disease
|
Sick sinus syndrome
|
Dowling-Degos disease
|
Bilateral sudden sensorineural hearing loss SUPERGRP Deafness, autosomal dominant
| 0 |
replace
|
19,279 |
プロアンサミトシンの別の言い方は?
|
GS-441524
|
N-Methylmescaline
|
Quinate
|
Proansamitocin
|
Protein N(omega)-phospho-L-arginine
| 3 |
replace
|
9,283 |
6-Aminohexanoate oligomerの異なる表現は?
|
Keratan
|
3'-O-Methylmyricetin
|
Bolasterone
|
Nylon-6 oligomer
|
Apigenin-6,8-di-C-glycoside
| 3 |
replace
|
14,348 |
C15H14O3の異なる表現は?
|
シラビオース
|
バミドチオン
|
β-ラパコン
|
cis-(Z)-Flupenthixol
|
(3Z)-4-(2-Carboxyphenyl)-2-oxobut-3-enoate
| 2 |
replace
|
31,185 |
Fawcettidineをを化学構造で書くと?
|
C17H17N5O2
|
C20H32
|
C16H24N2O14P2
|
C20H34NO15R
|
C16H23NO
| 4 |
formula
|
11,130 |
Diatrizoate meglumine (USP)の異なる名称は?
|
ジアトリゾ酸メグルミン
|
Afegostat tartrate (USAN)
|
Histamine (DCF)
|
イルベサルタン・トリクロルメチアジド
|
Dipyrocetyl (INN)
| 0 |
replace
|
34,030 |
(3S)-Pyridazin-3-carboxylateをを分子式で表すと?
|
C14H15N3
|
C6H5Cl
|
C21H27NO
|
C5H10N2O2
|
C13H23NO3
| 3 |
formula
|
30,661 |
C15H14O5の別名称は?
|
Cycloserine
|
ジヒドロタキステロール
|
Cobalt-sirohydrochlorin
|
Apiforol
|
Trimethobenzamide
| 3 |
replace
|
2,489 |
C8H14NOS2Rは別の呼び方では?
|
Achilleol B
|
[Lipoyl-carrier protein]-N6-(lipoyl)lysine
|
Neoglycyrol
|
Reduced hydrogenase
|
R.g.-Keto I
| 1 |
replace
|
34,377 |
C5H7O5Rを言い換えると?
|
D-threo-Aldono-1,5-lactone
|
Litorin
|
Sodium sulfate
|
メチルアゾキシメタノール酢酸
|
N-Acetylisoniazid
| 0 |
replace
|
23,889 |
イソバレルアルデヒドをを化学式で記述すると?
|
C21H23N3O7S2
|
C11H12N2S. HCl
|
C6H5NR2
|
(C6H8O7)n
|
C5H10O
| 4 |
formula
|
10,082 |
Lysophosphatidic acidをの組成式は?
|
C8H15NO
|
C4H8O7PR
|
C10H8O4
|
C9H15N3O11P2
|
C18H15ClN2O
| 1 |
formula
|
3,825 |
C27H30N4Oは別の呼び方では?
|
Celtect (TN)
|
Weil's disease and akiyami combined vaccine (JAN)
|
Nalidixate sodium monohydrate
|
Aluminum potassium sulfate hydrate and tannic acid
|
Hydroxocobalamin and isotonic sodium chloride solution
| 0 |
replace
|
2,635 |
脳・肋骨・下顎症候群の別呼称は?
|
Pulmonary surfactant metabolism dysfunction SUPERGRP Pulmonary alveolar proteinosis
|
Growth hormone insensitivity with immunodeficiency
|
Cerebellar hypoplasia, epilepsy, and global developmental delay
|
Carboxypeptidase N deficiency
|
Cerebrocostomandibular syndrome
| 4 |
replace
|
2,439 |
Hydroxychloroquineをは化学構造で表すと?
|
C7H9N5O
|
C6H6N2O3
|
C18H26ClN3O
|
C15H12O2
|
C10H12N4O4
| 2 |
formula
|
3,910 |
Inositol 1,2,4,5,6-pentakisphosphateの別表現は?
|
Coenzyme M disulfide
|
1D-myo-Inositol 1,2,4,5,6-pentakisphosphate
|
Thymosin beta-4
|
22-Hydroxydocosanoate
|
Neoabietal
| 1 |
replace
|
29,184 |
C26H42N7O18P3Sは別の呼び方では?
|
Octachlorocamphene
|
D-Galactosylglycosaminoglycan
|
2-Methyl-3-acetoacetyl-CoA
|
N-Benzoylglycine
|
Quinoxaline
| 2 |
replace
|
32,736 |
(2beta,5alpha,17beta)-17-(Acetyloxy)-2-fluoro-androstan-3-oneの別表現は?
|
Meglutol
|
2-N,6-N-Bis(2,3-dihydroxybenzoyl)-L-lysine amide
|
D-Lysine
|
4'''-Demalonylsalvianin
|
5alpha-Androstane-2beta-fluoro-17beta-ol-3-one acetate
| 4 |
replace
|
4,456 |
Amobamをの化学構造は?
|
C7H9NO3
|
C4H8N2S4. 2NH3
|
C110H203N2O42P3
|
C6H8O2
|
C19H26O3S2
| 1 |
formula
|
19,951 |
C180H235N67O101P16S16の別表現は?
|
ベサトリモド
|
Dilpacimab (USAN/INN)
|
イボクタデキン
|
セチルピリジニウム
|
Sepofarsen (USAN/INN)
| 4 |
replace
|
15,809 |
エセラミンをは化学式で表すと?
|
H2SeO4
|
C16H22N4O3
|
C28H46O7
|
C17H18N2O6S
|
C20H28O3
| 1 |
formula
|
7,061 |
スピラミンAの別名は?
|
Saccharocin
|
Strophanthidin 3-O-alpha-L-rhamnoside
|
L-Mimosine
|
Spiramine A
|
5-Fluoromuconolactone
| 3 |
replace
|
32,721 |
Hepatolithiasisの異なる名称は?
|
Garg-Mishra 早老症候群
|
総排泄腔遺残
|
FG 症候群
|
マイコプラズマ肺炎
|
肝内結石症
| 4 |
replace
|
20,904 |
C10H16O12P2R2(C5H8O6PR)nは別の呼び方では?
|
Chebulagic acid
|
Pantothenic acid
|
A28086B
|
RNA terminal-2',3'-cyclic-phosphate
|
all-trans-Retinol acetate
| 3 |
replace
|
18,313 |
5q- syndrome SUPERGRP Myelodysplastic syndrome の別表現は?
|
メチルマロン酸尿症およびホモシスチン尿症 下位グループ メチルマロン酸血症およびホモシスチン血症 cblX 型 上位グループ メチルマロン酸尿症 二次性高アンモニア血症
|
5q- 症候群 上位グループ 骨髄異形成症候群
|
内分泌系-脳-骨異形成症候群
|
偽膜性大腸炎 上位グループ 嫌気性菌感染症
|
月経周期依存性周期熱
| 1 |
replace
|
15,441 |
エルゾバンチニブをを化学構造で表すと?
|
C17H16N2OS
|
C20H20FN7O2
|
C6774H10418N1778O2096S46
|
C29H53INO4P
|
C33H43N3O6. HCl
| 1 |
formula
|
28,741 |
alpha-Hederinをを化学構造で書くと?
|
C20H34O
|
C19H21ClN2O
|
C8H18N4O
|
C28H48O5
|
C41H66O12
| 4 |
formula
|
7,885 |
D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphateの別名は?
|
(3S)-6-Hydroxy-3-isopropenyl-heptanoate
|
UH-301
|
(S)-NADPH-hydrate
|
Cinnamtannin A1
|
D-erythro-Imidazole-glycerol 3-phosphate
| 4 |
replace
|
14,154 |
イソプロピルアンチピリン・アリルイソプロピルアセチル尿素・フェナセチン・無水カフェインを言い換えると?
|
Fortizyme (TN)
|
Meclofenamate sodium (USP)
|
Isopropylantipyrine, allyl isopropyl acetyl urea, phenacetin and anhydrous caffeine
|
Seractide acetate hydrate
|
Gosuranemab (USAN)
| 2 |
replace
|
7,049 |
C11H12N2O2の別の言い方は?
|
フェンジメトラジン塩酸塩
|
トレゾリドリン酸エステル
|
Pridinol methanesulfonate
|
Tryptophan (USP/INN)
|
草豆蒄
| 3 |
replace
|
20,866 |
Rickettsialpoxの別の呼び方は?
|
リケッチア痘
|
グルタチオン合成酵素欠損症 上位グループ グルタチオン代謝障害による貧血
|
小角膜・近視性網脈絡膜萎縮および眼角隔離
|
病的肥満および精子形成不全
|
頭蓋-レンズ-縫合異形成
| 0 |
replace
|
15,820 |
EOB・プリモビスト(バイエル薬品)の別表現は?
|
Eovist (TN)
|
Dimethicone (NF)
|
Zibotentan (JAN/USAN/INN)
|
Dibenzothiophene (USAN)
|
Depo-provera (TN)
| 0 |
replace
|
19,522 |
tRNA containing N2-methylguanineをは組成式で表すと?
|
C6H5ClO4
|
C30H18O10
|
C4H4O5
|
C11H16N5O8P(C5H8O6PR)n(C5H8O6PR)n
|
C112H208N3O42P3
| 3 |
formula
|
2,539 |
Protochlorophyllideの別呼称は?
|
Complement component 3b
|
N-Hydroxyl-tryptamine
|
17,21-Epoxy-9-fluoro-11beta-hydroxyprogesterone
|
Protochlorophyllide a
|
Phenamil
| 3 |
replace
|
8,075 |
Enterolactoneをの化学式は?
|
C24H31FO6
|
C18H18O4
|
C11H17NO. HCl
|
C19H38O2
|
C23H24N2O
| 1 |
formula
|
25,125 |
Tanabalinをは分子式で表すと?
|
C3H7O6P
|
C31H42O10
|
C4H6N4O3S2
|
C38H64O3
|
C22H28O5
| 4 |
formula
|
1,221 |
C6450H9934N1718O2012S42の別名は?
|
テストステロンプロピオン酸エステル (JP18)
|
Cephalexin hydrochloride (USP)
|
Inobrodib (USAN)
|
ベコカルシジオール
|
Ogalvibart (USAN/INN)
| 4 |
replace
|
4,653 |
Spirolaurenoneの別表現は?
|
スピロラウレノン
|
ペモリン
|
Lactupicrin
|
alpha-D-Glucan
|
クニホロン
| 0 |
replace
|
20,647 |
C26H36O8の別記述は?
|
Erythromycin ethylsuccinate
|
all-trans-Retinoyl-beta-glucuronide
|
Ceramide phosphoethanolamine
|
Liposidomycin B
|
メリコピシン
| 1 |
replace
|
13,002 |
組織培養不活化ダニ媒介性脳炎ウイルスワクチンの別呼称は?
|
Olinciguat (USAN/INN)
|
Tiagabine hydrochloride (USP)
|
Homochlorcyclizine (INN)
|
Ticovac (TN)
|
Jogan'ippo
| 3 |
replace
|
14,119 |
MDCAの別記述は?
|
Prorocentrolide
|
Androst-4-ene-3alpha,17beta-diol diacetate
|
Methylenedioxycinnamic acid
|
N-Butyryl-L-homoserine lactone
|
Oxidized Renilla luciferin
| 2 |
replace
|
24,113 |
ジオウ(ウチダ和漢薬)の別の呼び方は?
|
Isoniazid (JP18/USP/INN)
|
Tiopronin (JAN/INN)
|
Mosnodenvir (USAN/INN)
|
Rehmannia root (TN)
|
Papaveretum (BAN)
| 3 |
replace
|
17,696 |
Ailanthoneをを化学構造で書くと?
|
C14H14NO4PS
|
C10H12O4
|
C9H12N2
|
C7H11N2O5R
|
C20H24O7
| 4 |
formula
|
8,745 |
C14H8Cl4の別呼称は?
|
1,1-Dichloro-2,2-bis(4'-chlorophenyl)ethylene
|
Digalactosylceramide sulfate
|
Antibiotic PS 5
|
(2E)-Octenoyl-CoA
|
Nogalavinone
| 0 |
replace
|
22,043 |
C17H18O2(C5H8)nの異なる表現は?
|
5-Hydroxy-4',6,7,8-tetramethoxyflavone
|
8-Methylmenaquinone
|
Fenapanil
|
Geranoyl-CoA
|
Digitonin
| 1 |
replace
|
20,648 |
3-Hydroxy-1-indanoneをは化学式で表すと?
|
C3H6AsO10P
|
C42H32O9
|
C17H20O6
|
C20H26O8
|
C9H8O2
| 4 |
formula
|
20,901 |
C2H4NO2R(C2H2NOR)nの別の呼び方は?
|
MAGE-3 (271 - 279)
|
Cyflumetofen
|
Peptide
|
2'-Hydroxypseudobaptigenin
|
Butanal
| 2 |
replace
|
693 |
N5-(L-1-Carboxyethyl)-L-ornithineをは化学構造で表すと?
|
C19H21NO3
|
C8H16N2O4
|
C21H25ClO3
|
C4H6O4R2
|
C5H8O5
| 1 |
formula
|
954 |
トルフェナム酸 (JAN)の別名称は?
|
Azatadine (INN)
|
Drozitumab (USAN/INN)
|
Thiophene-2-carbixylic acid
|
Pirprofen (USAN/INN)
|
Tolfenamic acid (JAN/INN)
| 4 |
replace
|
30,167 |
Hypoxyloneの異なる表現は?
|
1,3,7-Trimethyluric acid
|
アトラクチロシド
|
Methyridine
|
ニゲロース
|
ヒポキシロン
| 4 |
replace
|
29,847 |
2-Hydroxymethylbenzoic acidの別名称は?
|
Protein tyrosine phosphate
|
9alpha-Fluoro-6alpha-methylprednisolone
|
Diterpenoid SP-II
|
9,10-Dihydroxybenzo[a]pyrene
|
2-(Hydroxymethyl)benzoic acid
| 4 |
replace
|
24,679 |
Kufor-Rakeb syndromeの別名称は?
|
心臓弁形成異常 下位グループ 心臓弁発生異常 (CVDD)
|
常染色体劣性遺伝性巨頭症/巨脳症症候群
|
キャッシュバレーウイルス感染症
|
Kufor-Rakeb 症候群
|
ベネズエラ出血熱 上位グループ 南米出血熱 アレナウイルス性出血熱
| 3 |
replace
|
102 |
ビブナゾールの別呼称は?
|
Litronesib (USAN/INN)
|
Cyclobutyrol (INN)
|
Vistide (TN)
|
Vibunazole
|
Neumega (TN)
| 3 |
replace
|
6,835 |
(25S)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoAをを化学構造で表すと?
|
C13H18N4O3
|
C11H12Cl2N2O5
|
C48H80N7O20P3S
|
C8H11NO3
|
C5H10O5
| 2 |
formula
|
29,842 |
C20H16Oの異なる名称は?
|
3-[(Z)-8-Pentadecenyl]phenol
|
Stearoyl-[pcp]
|
7-Hydroxymethyl-12-methylbenz[a]anthracene
|
Carrageenan, degraded
|
4-Isonicotinoylnicotinamide
| 2 |
replace
|
29,949 |
Ocaliva (TN)をを化学式で書くと?
|
C12H17NO. HCl
|
C26H44O4
|
C564H909N161O166S5
|
C21H23N3O5. H2O
|
(C3H4O2)n
| 1 |
formula
|
30,834 |
Orthanilic acidの別の言い方は?
|
tRNA(Gly)
|
Penciclovir
|
o-Aminobenzenesulfonic acid
|
Abscisic acid glucose ester
|
1-O-(1Z-Tetradecenyl)-2-(9Z-octadecenoyl)-sn-glycerol
| 2 |
replace
|
34,211 |
beta-Butyrolactoneをの分子式は?
|
C28H31N2O3. Cl
|
C5H11O9P
|
C17H17N3O6S2
|
C4H6O2
|
C16H25NO3
| 3 |
formula
|
18,930 |
(+)-Borneolの異なる表記は?
|
Nickel-sirohydrochlorin
|
5-Methylaminomethyl-2-selenouridine in tRNA
|
(1R,2S,4R)-(+)-Borneol
|
BT1583
|
19-(4-Hydroxyphenyl)nonadecanoate
| 2 |
replace
|
30,183 |
A 80987をを分子式で表すと?
|
C11H11NO3
|
C37H43N5O6
|
C16H28O4
|
C21H25N3O3
|
C4H9NO3
| 1 |
formula
|
33,839 |
trans-2-(4-Nitrophenyl)-3-phenyloxiraneの異なる表記は?
|
Phospho-anandamide
|
cis-1,4-Polyisoprene
|
trans-4-Nitrostilbene oxide
|
Bacampicillin
|
3-Methoxyanthranilic acid
| 2 |
replace
|
17,277 |
Primary hypertrophic osteoarthropathyの別呼称は?
|
Kury-Isidor 症候群
|
家族性低カルシウム尿性高カルシウム血症 上位グループ カルシウム感知受容体 (CASR) 異常症
|
紅斑角皮症を伴う魚鱗癬
|
原発性肥厚性皮膚骨膜症
|
デント病 上位グループ X 連鎖性高カルシウム尿腎結石症
| 3 |
replace
|
24,488 |
Diabetic cardiomyopathyの別の呼び方は?
|
Faundes-Banka 症候群
|
毛孔性紅色粃糠疹
|
糖尿病性心筋症
|
ミトコンドリア複合体 I 欠損症 下位グループ ミトコンドリア複合体 I 欠損症、核型 (MC1DN) ミトコンドリア複合体 I 欠損症、ミトコンドリア型 上位グループ ミトコンドリア病
|
ウースター・ドロート症候群
| 2 |
replace
|
28,226 |
(Glutathione-S-yl)(1H-indol-3-yl)acetonitrileをの化学式は?
|
C2H4NO2R
|
C16H14
|
C20H32
|
C64H115N4O48P4R(R1)(R2)
|
C20H23N5O6S
| 4 |
formula
|
17,794 |
C15H26Oの別の呼び方は?
|
3',5'-Dichloro-2-hydroxy-2-methylbut-3-enanilide
|
Adenine in U6 snRNA
|
Glucobrassicanapin
|
3-O-(Carboxymethyl)estrone
|
(+)-tau-Muurolol
| 4 |
replace
|
6,632 |
C16H15ClN2O3Sの異なる名称は?
|
Anirolac (USAN/INN)
|
Sulofenur (USAN/INN)
|
Cattlyst (TN)
|
Tenocyclidine (INN)
|
Modotuximab (USAN/INN)
| 1 |
replace
|
12,173 |
Cetiedilをを化学構造で書くと?
|
C20H31NO2S
|
C25H40
|
C32H38N6O7S
|
C12H17N2O4P
|
C17H22N4O6
| 0 |
formula
|
27,634 |
3-Ethoxyandrosta-3,5-dien-17beta-ol propanoateをを化学式で書くと?
|
C24H36O3
|
C19H18N2O4
|
C92H201O140P25R2
|
C19H25FO2
|
C4H7NO4
| 0 |
formula
|
32,507 |
キセノン (非放射性) (JAN)の異なる名称は?
|
エモルファゾン (JP18)
|
Xenon (JAN)
|
モクボウイトウ
|
フロロピパミド
|
Glucurolactone (INN)
| 1 |
replace
|
16,503 |
15(S)-HPETEの別の呼び方は?
|
15-Hydroperoxyeicosatetraenoate
|
2-APB
|
alpha-Pinene-oxide
|
Paeonolide
|
N-Hydroxy-IQ
| 0 |
replace
|
12,879 |
C40H48N4O3の別呼称は?
|
Geissospermine
|
Dimethyl sulfone
|
[Glycine cleavage system H]-L-lysine
|
1,1'-Dimethyl-4,4'-bipyridinium
|
Oryzalexin A
| 0 |
replace
|
17,942 |
Glucosyl-4,4'-diaponeurosporenoateをを化学式で書くと?
|
C36H50O7
|
C9H8N2O2
|
C21H24N2O3
|
C23H45NO4
|
C11H14ClN5. HCl
| 0 |
formula
|
11,730 |
Bosentan (INN)をを化学式で表すと?
|
C14H8NO4. Na
|
C27H29N5O6S
|
C22H28N4O3
|
C35H55N5O6S2. HCl
|
C19H25NO. HBr
| 1 |
formula
|
29,860 |
オキシジスルホトンの別表現は?
|
Ketoaldehyde
|
Oxydisulfoton
|
L-Tyrosyl-L-arginine
|
alpha-NADH
|
3-Ethoxyandrosta-3,5-dien-17beta-ol propanoate
| 1 |
replace
|
9,065 |
塩酸キネロランの別の言い方は?
|
Cisapride (USP/INN)
|
Benadryl (TN)
|
Lades A (TN)
|
Detomidine hydrochloride (USAN)
|
Quinelorane hydrochloride (USAN)
| 4 |
replace
|
8,083 |
MC-7181をを化学式で記述すると?
|
C16H15NO2
|
C27H43N7O19P3SR
|
C32H41N5O5
|
C53H89O6P
|
C14H8Cl2FNO5
| 4 |
formula
|
12,356 |
Artil (TN)をを分子式で記述すると?
|
C12H12N2
|
C20H23NO
|
C16H24N2O5
|
C14H21NO2. HCl
|
C16H12O4
| 4 |
formula
|
16,147 |
(-)-Vestitolをを組成式で記述すると?
|
C10H14N4O11P2
|
C7H14O
|
C33H46O7
|
C61H101O9P
|
C16H16O4
| 4 |
formula
|
15,365 |
Pentabamate (USAN/INN)を言い換えると?
|
フェリステン
|
Neostigmine methylsulfate and inorganic salt
|
ペンタバマート
|
バンブテロール塩酸塩
|
Ieramilimab (USAN/INN)
| 2 |
replace
|
7,803 |
C59H90O4を使用した商品名は?
|
リザトリプタン(辰巳化学)
|
DOCETAXEL(AlembicPharmaceuticals)
|
後発品ヘモポリゾン(ジェイドルフ製薬)
|
後発品ユビデカレノン(日新製薬－山形)
|
ビダラビン(富士製薬工業)
| 3 |
product
|
13,069 |
Fusaproliferinは別の呼び方では?
|
D-Glucono-1,4-lactone
|
Deamino-NAD+
|
(-)-Fusaproliferin
|
Istamycin C0
|
Canaline
| 2 |
replace
|
11,569 |
ブリオフィリンAをは化学構造で表すと?
|
C21H20O8
|
C9H13NO6
|
C19H30N4O16P2
|
C6H12O9S
|
C26H32O8
| 4 |
formula
|
12,397 |
レミキレンの別表現は?
|
メチプリロン (JAN)
|
Remikiren (INN)
|
Oxogestone phenpropionate (USAN)
|
Magnesium aluminometasilicate and licorice extract
|
ヒャクソウソウ
| 1 |
replace
|
27,099 |
L-3-Aminobutyryl-CoAをは化学式で表すと?
|
C18H28N2O13PSR3(C5H8O6PR)n
|
C25H43N8O17P3S
|
C22H33NO2
|
C27H31O16
|
C6H11NO2S
| 1 |
formula
|
5,717 |
C20H18O7の別名は?
|
12alpha-Hydroxy-5beta-pregnane-3,20-dione
|
S-(5-Hydroxy-2-furoyl)-CoA
|
(13aS)-5,8,13,13a-Tetrahydro-3,10-dimethoxy-6H-dibenzo[a,g]quinolizine-2,9-diol
|
2-Hexanoyl-1,3,6,8-tetrahydroxy-9,10-anthraquinone
|
2,6-Dibromophenol
| 3 |
replace
|
11,344 |
Relapsing feverの別表現は?
|
回帰熱
|
ブーメラン異形成
|
免疫調節不全を伴うX連鎖性多臓器自己炎症疾患
|
偽軟骨異形成症 上位グループ 脊椎骨端異形成
|
ローレンス・ムーン症候群 上位グループ PNPLA6 関連疾患
| 0 |
replace
|
16,677 |
Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalitiesは別の呼び方では?
|
血管型出血性疾患
|
成長遅滞・早期の呼吸不全・ミオクロニー発作および脳の異常を伴う神経変性
|
遺伝性封入体ミオパチー 上位グループ 遠位型ミオパチー
|
長胴歯を伴うエナメル質形成不全・未成熟 上位グループ エナメル質形成不全症
|
早期乳児てんかん性脳症９型 上位グループ 早期乳児てんかん性脳症 症候性全般てんかん
| 1 |
replace
|
7,241 |
ペニトレムFを言い換えると?
|
C-Terminal [mycofactocin precursor peptide]-glycyl-L-valyl-4-[2-aminoethenyl]phenol
|
Fluperlapine
|
Penitrem F
|
3'-Hydroxyflavone
|
Haloxydine
| 2 |
replace
|
19,073 |
ジランテルをを組成式で書くと?
|
C6H10N6O
|
C26H38N2O6P2S4
|
C27H37N3O7S. C3H8O2
|
C24H30N2O2S
|
C21H19ClN4O4. CH4SO3
| 1 |
formula
|
3,367 |
Endecto (TN)の異なる名称は?
|
Kerendia (TN)
|
Propylhexedrine hydrochloride
|
Pamrevlumab (USAN/INN)
|
Scoolia (TN)
|
Abamectin (USAN/INN)
| 4 |
replace
|
7,861 |
Zinc carbonate (USP)をを化学構造で表すと?
|
CH2O3. Zn
|
C23H32N6O4S. HCl
|
C23H22ClN3O2
|
C10H7Cl3N4
|
C694H1121N181O205S6
| 0 |
formula
|
31,090 |
Heterodendrinの別の言い方は?
|
3-メチルチオフェンタニル
|
tRNA containing N2-methylguanine
|
トシル酸スルタミシリン
|
エチシクリジン
|
ヘテロデンドリン
| 4 |
replace
|
27,184 |
(-)-Annonaineをの組成式は?
|
C32H24O5
|
C14H13NO
|
C17H15NO2
|
C20H29NO5S
|
C6H6N2O3
| 2 |
formula
|
15,476 |
C10H7Cl2NOの別の呼び方は?
|
Chlorquinaldol (INN)
|
Techne phytate (TN)
|
Adreview (TN)
|
Crotedumab (USAN/INN)
|
Erythromycin salnacedin dihydrate
| 0 |
replace
|
3,808 |
Taribavirin hydrochloride (USAN)の別名は?
|
硫酸トリメトプリム
|
タリバビリン塩酸塩
|
ロベリン硫酸塩
|
フルドロコルチゾン
|
Depatuxizumab mafodotin (genetical recombination) (JAN)
| 1 |
replace
|
34,189 |
C10H16N3O7P(C5H8O5PR)n(C5H8O5PR)nの別表現は?
|
(+/-)-Carnegine
|
Mallogenin-3-o-alpha-L-rhamnopyranoside
|
2-Butyloctan-1-ol
|
DNA N4-methylcytosine
|
Amarogentin
| 3 |
replace
|
4,222 |
(5Z,11Z,14Z,17Z)-Icosa-5,11,14,17-tetraenoyl-CoAをの化学式は?
|
C41H66N7O17P3S
|
C27H38N2O4
|
C16H14O6
|
C42H51NO15
|
C15H13N3O2
| 0 |
formula
|
4,249 |
好酸球ペルオキシダーゼ欠損の別記述は?
|
Very long-chain acyl-CoA dehydrogenase deficiency SUPERGRP Disorders of mitochondrial fatty-acid oxidation Secondary hyperammonemia Mitochondrial disease
|
Muenke syndrome
|
Larsen syndrome SUBGROUP Larsen-like syndrome Joint laxity, short stature, and myopia
|
Trichohepatoneurodevelopmental syndrome
|
Eosinophil peroxidase deficiency
| 4 |
replace
|
2,603 |
Myolastan (TN)の別表現は?
|
テトラゼパム
|
Elasomeran (JAN) and imelasomeran (JAN)
|
3-ヨードベンジルグアニジン (131I) (JAN)
|
エテルカルセチド
|
Batanopride hydrochloride (USAN)
| 0 |
replace
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.